Zurich-based Dr. Rubio, a board‑certified Medical Oncologist with more than 15 years of clinical experience and over two decades in the pharmaceutical and CRO industries, has been appointed to a senior leadership position overseeing global oncology development and medical monitoring operations at Theradex Oncology.
Medically trained in Argentina and The Netherlands, Dr. Rubio has built an international career defined by scientific rigor and operational excellence. Since relocating to Zurich in 2017, he has taken on expanding regional and global responsibilities, becoming a key medical leader in oncology drug development.